Related Experiment Videos
Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction
1Department of Medicine, University of Massachusetts Medical School, Worcester.
Insights
A new classification for left ventricular (LV) dysfunction categorizes patients by systolic function, aiding treatment and prognosis. Medical therapy benefits both symptomatic and asymptomatic patients with LV dysfunction.
Area of Science:
- Cardiology
- Clinical Medicine
Background:
- Left ventricular (LV) dysfunction encompasses systolic and diastolic impairments with distinct pathophysiology, treatment responses, and prognoses.
- Current terminology like congestive heart failure inadequately captures these critical differences.
- Medical interventions demonstrate efficacy in LV dysfunction irrespective of symptomatic status.
Purpose of the Study:
- To introduce a novel classification system for LV dysfunction based on systolic function.
- To enable better differentiation of patients for tailored treatment and prognostic assessment.
- To provide a framework applicable to both symptomatic and asymptomatic individuals.
Main Methods:
- Categorization of LV dysfunction based on normal or abnormal systolic function.
- Assessment of LV ejection fraction to distinguish between systolic and diastolic dysfunction.
- Analysis of clinical trial data to evaluate treatment benefits and prognosis across categories.
Main Results:
- Patients with LV systolic dysfunction (ejection fraction < 40%) benefit from therapy, symptomatic or not.
- Patients with diastolic dysfunction (normal ejection fraction) also show benefits from medical therapy.
- Mortality rates are higher in systolic dysfunction compared to diastolic dysfunction, and higher in symptomatic patients within each group.
Conclusions:
- The proposed classification system effectively distinguishes LV systolic and diastolic dysfunction.
- This classification aids in personalized diagnosis, treatment strategies, and epidemiological studies of heart failure.
- It underscores the importance of medical therapy for LV dysfunction, regardless of symptoms or specific type.
Abstract:
Data from large and small clinical trials reflect major differences in the pathophysiology, treatment, and prognosis of left ventricular (LV) systolic and diastolic dysfunction. These studies also indicate that medical therapy can benefit patients with LV dysfunction regardless of whether or not they are symptomatic. Because the descriptive term congestive heart failure does not provide for these important distinctions, a new classification of LV dysfunction has been developed in which patients with LV dysfunction are categorized on the basis of normal or abnormal systolic function. This classification is based on a simple assessment of LV function, it is applicable to patients without symptoms, and it reflects differences in treatment and prognosis. Those with clinically significant LV systolic dysfunction (ie, an LV ejection fraction < 40%) benefit from therapy whether or not they have symptoms of heart failure. Those with LV dysfunction and a normal LV ejection fraction (ie, diastolic dysfunction) also benefit from medical therapy. Annual mortality is higher in those with systolic dysfunction than in those with diastolic dysfunction, but within each of these categories mortality is higher in those with symptoms than in those without. This classification can be useful in the diagnosis and treatment of individual patients as well as in epidemiologic surveys designed to assess medical practice patterns.